Patents by Inventor Mutlu Karakelle

Mutlu Karakelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9579191
    Abstract: An ophthalmic lens system comprises a lens body with a curved outer surface and an assembly including a plurality of spaced apart nanostructures. The assembly covers at least a portion of the curved outer surface.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: February 28, 2017
    Assignee: Novartis AG
    Inventors: Xin Hong, David Meadows, Qiwen Zhan, Mutlu Karakelle
  • Patent number: 9078745
    Abstract: An ophthalmic lens includes an optical filter operable to filter out at least visible light having a wavelength less than 450 nm. The lens also includes a first diffractive structure adapted to produce a focus for visible light in a first wavelength range above 550 nm and to reduce longitudinal chromatic aberration to less than one diopter for incoming visible light in the first wavelength range. The lens also includes a second diffractive structure outside the first diffractive structure in a radial direction and adapted to produce a focus for visible light in a second wavelength range between 450 nm and 550 nm. The second diffractive structure is also adapted to reduce longitudinal chromatic aberration for incoming visible light in the second wavelength range to less than one diopter while allowing longitudinal chromatic aberration in the first wavelength range in an amount greater than the first diffractive structure.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: July 14, 2015
    Assignee: NOVARTIS AG
    Inventors: Xiaoxiao Zhang, Costin Eugene Curatu, Krishnakumar Venkateswaran, Daniel Robert Carson, Mutlu Karakelle, Xin Hong, Yueai Liu
  • Patent number: 9039762
    Abstract: An accommodating intraocular lens (AIOL) includes an optic adapted to produce a trapezoidal phase shift and a plurality of haptics. Each haptic extends from a haptic-optic junction to at least one transverse arm contacting a capsular bag of the eye, and each haptic has sufficient length and rigidity to stretch a capsular bag of the eye to contact ciliary muscles of the eye. The haptic-optic junctions vault the optic forward relative to the haptics and compression of the haptics by the ciliary muscles moves the anterior optic forward. A combined accommodative power produced by the motion of the anterior optic and the trapezoidal phase shift is at least 0.5 Diopters.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: May 26, 2015
    Assignee: Novartis AG
    Inventors: Xin Hong, Mutlu Karakelle, Son Tran, Xiaoxiao Zhang, Myoung-Taek Choi
  • Patent number: 8852273
    Abstract: In one aspect, the present invention provides a method of designing an intraocular lens (IOL) to address variations of at least one ocular parameter in a population of patient eyes. The method can include establishing at least one eye model in which the ocular parameter can be varied over a range exhibited by the population. The eye model can be employed to evaluate a plurality of IOL designs in correcting visual acuity for eyes in the patient population. An IOL design that provides a best fit for visual performance over at least a portion of the parameter range can then be selected.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: October 7, 2014
    Assignee: Novartis AG
    Inventors: Xin Hong, Mutlu Karakelle, Xiaoxiao Zhang
  • Patent number: 8821572
    Abstract: An intraocular lens (IOL) delivery device is disclosed. The device includes an intraocular lens cartridge having an internal coating wherein the coating includes a polymeric material that is compatible with a polymeric material of a material that forms the cartridge. Preferably, the polymeric material of the coating, the cartridge or both is a polyurethane material.
    Type: Grant
    Filed: November 18, 2009
    Date of Patent: September 2, 2014
    Assignee: Alcon Research, Ltd.
    Inventors: Mutlu Karakelle, David A. Downer, Sushant Muchhala
  • Publication number: 20140194986
    Abstract: An ophthalmic lens includes an optical filter operable to filter out at least visible light having a wavelength less than 450 nm. The lens also includes a first diffractive structure adapted to produce a focus for visible light in a first wavelength range above 550 nm and to reduce longitudinal chromatic aberration to less than one diopter for incoming visible light in the first wavelength range. The lens also includes a second diffractive structure outside the first diffractive structure in a radial direction and adapted to produce a focus for visible light in a second wavelength range between 450 nm and 550 nm. The second diffractive structure is also adapted to reduce longitudinal chromatic aberration for incoming visible light in the second wavelength range to less than one diopter while allowing longitudinal chromatic aberration in the first wavelength range in an amount greater than the first diffractive structure.
    Type: Application
    Filed: March 11, 2014
    Publication date: July 10, 2014
    Applicant: NOVARTIS AG
    Inventors: XIAOXIAO ZHANG, COSTIN EUGENE CURATU, KRISHNAKUMAR VENKATESWARAN, DANIEL ROBERT CARSON, MUTLU KARAKELLE, XIN HONG, YUEAI LIU
  • Patent number: 8709079
    Abstract: An ophthalmic lens includes an optical filter operable to filter out at least visible light having a wavelength less than 450 nm. The lens also includes a first diffractive structure adapted to produce a focus for visible light in a first wavelength range above 550 nm and to reduce longitudinal chromatic aberration to less than one diopter for incoming visible light in the first wavelength range. The lens also includes a second diffractive structure outside the first diffractive structure in a radial direction and adapted to produce a focus for visible light in a second wavelength range between 450 nm and 550 nm. The second diffractive structure is also adapted to reduce longitudinal chromatic aberration for incoming visible light in the second wavelength range to less than one diopter while allowing longitudinal chromatic aberration in the first wavelength range in an amount greater than the first diffractive structure.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: April 29, 2014
    Assignee: Novartis AG
    Inventors: Xiaoxiao Zhang, Costin Eugene Curatu, Krishnakumar Venkateswaran, Daniel Robert Carson, Mutlu Karakelle, Xin Hong, Yueai Liu
  • Patent number: 8652205
    Abstract: A diffractive multifocal design for ocular implant is provided. This ocular implant includes a diffractive multifocal intraocular lens (IOL) and a number of haptics. The diffractive multifocal IOL passes optical energy to distance, intermediate and near foci. The haptics mechanically couple to the diffractive multifocal IOL in order to position and secure the diffractive multifocal IOL within the eye. The diffractive multifocal IOL may include both a diffractive region and a refractive region, the diffractive multifocal IOL operable to phase shift optical energy such that constructive interference occurs within the diffractive region and the refractive region.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: February 18, 2014
    Assignee: Novartis AG
    Inventors: Xin Hong, Mutlu Karakelle, Xioaxioa Zhang
  • Patent number: 8562675
    Abstract: In one aspect, the present invention provides an ophthalmic lens (e.g., an IOL) that includes an optic having an anterior surface and a posterior surface disposed about an optical axis. At least one of the surfaces (e.g., the anterior surface) has a profile characterized by superposition of a base profile and an auxiliary profile. The auxiliary profile can include an inner region, an outer region and a transition region between the inner and the outer regions, where an optical path difference across the transition region (i.e., the optical path difference between the inner and the outer radial boundaries of the transition region) corresponds to a non-integer fraction (e.g., ½) of a design wavelength (e.g., a wavelength of about 550 nm).
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: October 22, 2013
    Assignee: Novartis AG
    Inventors: Xin Hong, Mutlu Karakelle, Xiaoxiao Zhang, Michael Simpson, Myoung Choi, Yan Zhang
  • Patent number: 8556417
    Abstract: In certain embodiments, an ophthalmic lens comprises an optic. The optic has an optical axis and surfaces comprising an anterior surface and a posterior surface. At least one of the surfaces has an inner refractive region and a refractive-diffractive structure disposed outwardly from the inner refractive region in a direction away from the optical axis. The inner refractive region is adapted to contribute refractively to a distance focus optical power. The refractive-diffractive structure comprises one or more diffractive regions and one or more refractive regions. A diffractive region is adapted to contribute diffractively to a multi-zone optical power, and a refractive region is adapted to contribute refractively to the distance focus optical power.
    Type: Grant
    Filed: February 2, 2012
    Date of Patent: October 15, 2013
    Assignee: Novartis AG
    Inventors: Kamal K. Das, Mutlu Karakelle
  • Patent number: 8529058
    Abstract: In one aspect, the present invention provides a method for correcting vision that employs two lenses, at least one of which is a multifocal lens, with different focusing characteristics for use in the two eyes of the patient. The visual performance of each lens (e.g., visual contrast or acuity) is selected in accordance with a predefined relation so as to optimize the binocular visual performance provided by the combination of the lenses.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: September 10, 2013
    Assignee: Novartis AG
    Inventors: Xin Hong, Mutlu Karakelle, Xiaoxiao Zhang, Arthur Bradley
  • Publication number: 20130201445
    Abstract: In certain embodiments, an ophthalmic lens comprises an optic. The optic has an optical axis and surfaces comprising an anterior surface and a posterior surface. At least one of the surfaces has an inner refractive region and a refractive-diffractive structure disposed outwardly from the inner refractive region in a direction away from the optical axis. The inner refractive region is adapted to contribute refractively to a distance focus optical power. The refractive-diffractive structure comprises one or more diffractive regions and one or more refractive regions. A diffractive region is adapted to contribute diffractively to a multi-zone optical power, and a refractive region is adapted to contribute refractively to the distance focus optical power.
    Type: Application
    Filed: February 2, 2012
    Publication date: August 8, 2013
    Inventors: Kamal K. Das, Mutlu Karakelle
  • Publication number: 20120290085
    Abstract: In one aspect, the present invention provides an ophthalmic lens (e.g., an IOL) that includes an optic having an anterior surface and a posterior surface disposed about an optical axis. At least one of the surfaces (e.g., the anterior surface) has a profile characterized by superposition of a base profile and an auxiliary profile. The auxiliary profile can include an inner region, an outer region and a transition region between the inner and the outer regions, where an optical path difference across the transition region (i.e., the optical path difference between the inner and the outer radial boundaries of the transition region) corresponds to a non-integer fraction (e.g., ½) of a design wavelength (e.g., a wavelength of about 550 nm).
    Type: Application
    Filed: July 30, 2012
    Publication date: November 15, 2012
    Inventors: Xin Hong, Mutlu Karakelle, Xiaoxiao Zhang, Michael Simpson, Myoung Choi, Yan Zhang
  • Publication number: 20120262670
    Abstract: In one aspect, the present invention provides a method of designing an intraocular lens (IOL) to address variations of at least one ocular parameter in a population of patient eyes. The method can include establishing at least one eye model in which the ocular parameter can be varied over a range exhibited by the population. The eye model can be employed to evaluate a plurality of IOL designs in correcting visual acuity for eyes in the patient population. An IOL design that provides a best fit for visual performance over at least a portion of the parameter range can then be selected.
    Type: Application
    Filed: June 22, 2012
    Publication date: October 18, 2012
    Inventors: Xin Hong, Mutlu Karakelle, Xiaoxiao Zhang
  • Publication number: 20120259411
    Abstract: An ophthalmic lens system comprises a lens body with a curved outer surface and an assembly including a plurality of spaced apart nanostructures. The assembly covers at least a portion of the curved outer surface.
    Type: Application
    Filed: April 4, 2012
    Publication date: October 11, 2012
    Applicant: Novartis AG
    Inventors: Xin Hong, David Meadows, Qiwen Zhan, Mutlu Karakelle
  • Patent number: 8241354
    Abstract: In one aspect, the present invention provides an ophthalmic lens (e.g., an IOL) that includes an optic having an anterior surface and a posterior surface disposed about an optical axis. At least one of the surfaces (e.g., the anterior surface) has a profile characterized by superposition of a base profile and an auxiliary profile. The auxiliary profile can include an inner region, an outer region and a transition region between the inner and the outer regions, where an optical path difference across the transition region (i.e., the optical path difference between the inner and the outer radial boundaries of the transition region) corresponds to a non-integer fraction (e.g., ½) of a design wavelength (e.g., a wavelength of about 550 nm).
    Type: Grant
    Filed: July 15, 2009
    Date of Patent: August 14, 2012
    Assignee: Novartis AG
    Inventors: Xin Hong, Mutlu Karakelle, Xiaoxiao Zhang, Michael Simpson, Myoung Choi, Yan Zhang
  • Patent number: 8231673
    Abstract: An improved multifocal design for an ocular implant is provided. This ocular implant includes an intraocular lens (IOL) and a number of haptics. The IOL passes optical energy. A microstructure within the IOL places the IOL under tension. The microstructure is operable to be broken in a controlled manner to release tension in the IOL and reshape the IOL. This may be done at any time post operatively and in conjunction with wavefront aberrometry to provide improved results. The haptics mechanically couple to the IOL in order to position and secure the IOL within the eye.
    Type: Grant
    Filed: May 1, 2009
    Date of Patent: July 31, 2012
    Assignee: Novartis AG
    Inventors: Alex Sacharoff, Mutlu Karakelle
  • Patent number: 8211172
    Abstract: In one aspect, the present invention provides a method of designing an intraocular lens (IOL) to address variations of at least one ocular parameter in a population of patient eyes. The method can include establishing at least one eye model in which the ocular parameter can be varied over a range exhibited by the population. The eye model can be employed to evaluate a plurality of IOL designs in correcting visual acuity for eyes in the patient population. An IOL design that provides a best fit for visual performance over at least a portion of the parameter range can then be selected.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: July 3, 2012
    Assignee: Novartis AG
    Inventors: Xin Hong, Mutlu Karakelle, Xiaoxiao Zhang
  • Patent number: 8100527
    Abstract: In one aspect, the present invention provides a method of correcting vision, which comprises determining a residual accommodation exhibited by a natural, crystalline lens of an eye, and selecting a multifocal intraocular lens (IOL), which exhibits a far-focus optical power (e.g., in a range of about ?15 to about +50 Diopters (D)) and an add power (e.g., in a range of about 1 D to about 4 D), for implantation in the eye while retaining the natural lens. The add power of the IOL is selected as a function of the residual accommodation such that a combination of the IOL and the natural lens provides a visual contrast greater than about 10% at a spatial frequency of about 20 cycles/degree for viewing objects at a distance greater than about 30 cm from the eye.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: January 24, 2012
    Assignee: Novartis AG
    Inventors: Xin Hong, Mutlu Karakelle, Xiaoxiao Zhang
  • Patent number: RE45969
    Abstract: In one aspect, the present invention provides an ophthalmic lens (e.g., an IOL) that includes an optic having an anterior surface and a posterior surface disposed about an optical axis. At least one of the surfaces (e.g., the anterior surface) has a profile characterized by superposition of a base profile and an auxiliary profile. The auxiliary profile can include an inner region, an outer region and a transition region between the inner and the outer regions, where an optical path difference across the transition region (i.e., the optical path difference between the inner and the outer radial boundaries of the transition region) corresponds to a non-integer fraction (e.g., ½) of a design wavelength (e.g., a wavelength or about 550 nm).
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: April 12, 2016
    Assignee: NOVARTIS AG
    Inventors: Xin Hong, Myoung-Taek Choi, Mutlu Karakelle, Xiaoxiao Zhang, Michael J. Simpson, Yan Zhang